Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4474195
Max Phase: Preclinical
Molecular Formula: C5H10N2O2
Molecular Weight: 130.15
Molecule Type: Unknown
Associated Items:
ID: ALA4474195
Max Phase: Preclinical
Molecular Formula: C5H10N2O2
Molecular Weight: 130.15
Molecule Type: Unknown
Associated Items:
Canonical SMILES: O=C(O)C1CCCNN1
Standard InChI: InChI=1S/C5H10N2O2/c8-5(9)4-2-1-3-6-7-4/h4,6-7H,1-3H2,(H,8,9)
Standard InChI Key: BZIBRGSBQKLEDC-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: Yes | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 130.15 | Molecular Weight (Monoisotopic): 130.0742 | AlogP: -0.67 | #Rotatable Bonds: 1 |
Polar Surface Area: 61.36 | Molecular Species: ACID | HBA: 3 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 4.06 | CX Basic pKa: 5.81 | CX LogP: -2.01 | CX LogD: -3.40 |
Aromatic Rings: 0 | Heavy Atoms: 9 | QED Weighted: 0.44 | Np Likeness Score: 0.85 |
1. Khatra H, Kundu J, Khan PP, Duttagupta I, Pattanayak S, Sinha S.. (2016) Piperazic acid derivatives inhibit Gli1 in Hedgehog signaling pathway., 26 (18): [PMID:27528433] [10.1016/j.bmcl.2016.08.008] |
Source(1):